Ingredient Analysis

Quantitative analysis of 13 pharmacodynamic components in Yinqiao Huopu Tuire mixture*

Expand
  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China

Revised date: 2022-04-14

  Online published: 2024-06-26

Abstract

Objective: To set up a simultaneous determination method of 13 components in Yinqiao Huopu Tuire mixture (Xinguan 2) including neochlorogenic acid, caffeic acid, chlorogenic acid, amygdalin, forsythoside B, forsythoside A, isochlorogenic acid B, isochlorogenic acid A, isochlorogenic acid C, forsythin, arctiin, magnolol and honokiol by HPLC-DAD wavelength switching method. Methods: Agilent ZORBAX SB-C18 column (250 mm×4.6 mm, 5 μm) was adopted. The mobile phase composed of methanol, acetonitrile, purified water and phosphoric acid with gradient elution. The flow rate was 1.0 mL·min-1; the column temperature was 40 ℃, and the detection wavelength were 327 nm(0-42 min, neochlorogenic acid), 207 nm (42-60 min, caffeic acid, chlorogenic acid and amygdalin), 327 nm (60-113.5 min, forsythoside A and forsythoside B, isochlorogenic acid A, isochlorogenic acid B and isochlorogenic acid C) and 228 nm(113.5-144 min, forsythin and arctiin) and 210 nm (144-160 min, magnolol and honokiol). Results: The separation of 13 components was good, and there was a good linear relationship between the peak area and the injection quantity of 13 components in the ranges of 0.013 7-0.274 μg·mL-1 (r=0.999 9), 0.009 24-0.185 μg·mL-1 (r=0.999 9), 0.122-2.444 μg·mL-1(r=1.000), 0.019 8-0.396 0 μg·mL-1 (r=0.999 9), 0.012 8-0.257 μg·mL-1(r=1.000), 0.023 1-0.461 μg·mL-1 (r=0.999 9), 0.031 4-0.628 μg·mL-1(r=0.999 9), 0.300-5.992 μg·mL-1 (r=0.999 9), 0.022 0-0.441 μg·mL-1 (r=0.999 9), 0.009 66-0.193 2 μg·mL-1 (r=0.999 9), 0.043 8-0.876 μg·mL-1 (r=0.999 9), 1.452×10-3-0.029 0 μg·mL-1 (r=0.999 8) and 0.660×10-3-0.013 2 μg·mL-1(r=0.999 8), respectively, and the recovery rates were 100.1(RSD=0.78%), 98.9%(RSD=1.1%), 99.8%(RSD=0.72%), 99.7%(RSD=0.61%), 99.9%(RSD=0.38%), 99.6%(RSD=0.17%), 100.3%(RSD=0.87%), 99.6%(RSD=0.21%), 99.9%(RSD=0.64%), 99.6%(RSD=0.91%), 100.0%(RSD=0.55%), 99.3%(RSD=0.21%), 98.9%(RSD=0.67%), respectively. The content ranges of neochlorogenic acid, caffeic acid, chlorogenic acid, amygdalin, forsythoside B, forsythoside A, isochlorogenic acid B, isochlorogenic acid A, isochlorogenic acid C, forsythin, arctiin, magnolol and honokiol in three batches of samples were 0.378-0.399 mg·mL-1, 0.080 8-0.085 1 mg·mL-1, 2.193-2.302 mg·mL-1, 0.815-0.878 mg·mL-1, 0.235-0.257 mg·mL-1, 1.877-1.978 mg·mL-1, 0.315 -0.334 mg·mL-1, 0.479-0.493 mg·mL-1, 0.653-0.667 mg·mL-1, 0.223-0.234 mg·mL-1, 1.198-1.258 mg·mL-1, 0.068 1-0.072 1 mg·mL-1 and 0.092 0-0.094 0 mg·mL-1, respectively. Conclusion: The quantitative analysis method established by HPLC-DAD wavelength switching method is proved to meet the requirements, and 13 effective components in Yinqiao Huopu Tuire mixture(Xinguan 2) can be detected at the same time, which provides a scientific basis for the quality control and evaluation of the preparation.

Cite this article

YUAN Qiang-hua, XIE Fan, TAN Jing, LIN Zhi, SHENG Rong, HU Mei, ZHENG Yan . Quantitative analysis of 13 pharmacodynamic components in Yinqiao Huopu Tuire mixture*[J]. Chinese Journal of Pharmaceutical Analysis, 2022 , 42(4) : 598 -606 . DOI: 10.16155/j.0254-1793.2022.04.06

References

[1] ELFIK AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19[J].Life Sci, 2020, 248:117477
[2] LI JY, YOU Z, WANG Q, et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future[J].Microbes Infect, 2020, 22(2): 80
[3] 李艳超, 白万柱, 端川勉. 潜在的神经侵袭特性可能是新型冠状病毒肺炎患者呼吸窘迫的原因之一[J].医学争鸣, 2020, 11(1): 7
LI YC, BAI WZ, TSUTOMU H. Potential neuroinvasion may be one cause of respiratory distress in COVID-19 patients[J].Negative, 2020, 11(1): 7
[4] 周琬琰, 陈烨. 新型冠状病毒肺炎的消化系统特征与粪口传播问题[J].现代消化及介入诊疗, 2020, 25(2): 143
ZHOU WY, CHEN Y. The digestive system characteristics and the fecal-oral transmission problems of COVID-19[J].Mod Dig Interv, 2020, 25(2): 143
[5] 王亚楠, 杨春光, 肖俊, 等. 新型冠状病毒感染肺炎背景下泌尿外科诊疗防控工作建议[J].现代泌尿外科杂志, 2020, 25(2): 95
WANG YN, YANG CG, XIAO J, et al. Guidelines of prevention and control of COVID-19 in urology departments[J].J Mod Urol, 2020, 25(2): 95
[6] 韩园园, 赵梦冉, 石垚, 等. 中西医结合治疗新型冠状病毒肺炎的应用分析[J].中草药, 2020, 51(4): 878
HAN YY, ZHAO MR, SHI Y, et al. Application of integrative medicine protocols in treatment of coronavirus disease 2019[J].Chin Tradit Herb Drugs, 2020, 51(5):878
[7] 刘闰平, 葛俊德, 钟颖, 等. 基于干预细胞因子风暴文献挖掘的中医药治疗重症新型冠状病毒肺炎探讨[J].中草药, 2020, 51(5): 1096
LIU RP, GE JD, ZHONG Y, et al. Traditional Chinese medicine for treatment of COVID-19 based on literature mining of targeting cytokine storm[J].Chin Tradit Herb Drugs, 2020, 51(5): 1096
[8] LOU Z, WANG H, ZHU S, et al. Antibacterial activity and mechanism of action of chlorogenic acid[J].J Food Sci, 2011, 76(6): M398
[9] LI G, WANG X, XU Y, et al. Antimicrobial effect and mode of action of chlorogenic acid on Staphylococcus aureus[J].Eur Food Res Technol, 2014, 238(4):589
[10] DING Y, CAO Z, CAO L, et al. Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase[J].Sci Rep, 2017, 7: 45723
[11] 李祖晟, 朱志安. 二咖啡酰奎宁酸药理实验研究进展[J].医学综述, 2004, 10(4):249
LI ZS, ZHU ZA. Pharmacological experimental research progress of dicaffeoylquinic acids[J].Med Recapit, 2004, 10(4): 249
[12] 王彬辉, 章文红, 张晓芬, 等. 苦杏仁苷提取工艺及药理作用研究新进展[J].中华中医药学刊, 2014, 32(2): 381
WANG BH, ZHANG WH, ZHANG XF, et al. New research progress on extraction process and harmacological effects of amygdalin[J].Chin Arch Tradit Chin Med, 2014, 32(2):381
[13] 吴国友. 连翘药理作用研究进展[J].中医学报, 2013, 28(10): 1508
WU GY. Research progress on pharmacological action of Forsythia suspensa[J].China J Chin Med, 2013, 28(10):1508
[14] 范小青, 申云富. 牛蒡苷药理活性研究进展[J].上海中医药杂志, 2017, 51(4):113
FAN XQ, SHEN YF. Research progress on pharmacological activities of arctiin[J].Shanghai J Tradit Chin Med, 2017, 51(4):113
[15] 石征蓉, 谷江华, 杨秀青, 等. 川银花-黄芩药对配伍前后指纹图谱的变化及其多指标成分的定量分析[J].中国实验方剂学杂志, 2017, 23(18): 24
SHI ZR, GU JH, YANG XQ, et al. Change of fingerprints and quantitative analysis of multi-index constituents in couplet medicines of Lonicerae Similis Flos-Scutellariae Radix before and after compatibility[J].Chin J Exp Tradit Med Form, 2017, 23(18): 24
[16] 乔凤仙, 蔡皓, 屠鹏飞, 等. 一测多评法在牛蒡子生制品质量评价中的应用[J].中药新药与临床药理, 2015, 26(4): 535
QIAO FX, CAI H, TU PF, et al. Quality evaluation of crude and processed Fructus Arctii by quantitative analysis of multi-components by single marker[J].Tradit Chin Drug Res Clin Pharmacol, 2015, 26(4): 535
[17] 曹静亚, 李智宁, 李飞飞, 等. 连翘药材、标准汤剂、中间体和配方颗粒的HPLC指纹图谱相关性[J].中国医药工业杂志, 2019, 50(3): 102
CAO JY, LI ZN, LI FF, et al. Correlation on HPLC fingerprint spectra of raw herbs, standard decoction, intermediates and dispensing granules of Forsythia suspense[J].Chin J Pharm, 2019, 50(3): 102
[18] 荆文光, 邓哲, 孙晓波, 等. 姜厚朴饮片标准汤剂研究[J].中草药, 2019, 50(1): 86
JING WG, DENG Z, SUN XB, et al. Research on standard decoction of ginger juice Magnoliae Officinalis Cortex[J].Chin Tradit Herb Drugs, 2019, 50(1): 86
[19] 杜冠华, 王月华, 张冉, 等. 多成分多靶点是对中药作用机制的表面认识[J].世界科学技术-中医药现代化, 2009, 11(4): 480
DU GH, WANG YH, ZHANG R, et al. Multiple ingredients target is the surface of the mechanism of TCM[J].World Sci Technol Mod Tradit Chin Med, 2009, 11(4): 480
[20] 王勇, 李春, 仇琪, 等. 中药复方多成分多靶点协同增效药理药效评价体系[J].中国科学: 生命科学, 2016, 46(8): 1029
WANG Y, LI C, QIU Q, et al. Chinese medicine compound composition more targets more synergies pharmacological efficacy evaluation system[J].China Sci: Life Sci, 2016, 46(8): 1029
Outlines

/